Clinical trial
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in…
NCT00006123 · Beth Israel Deaconess Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00006123 |
|---|---|
| Title | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer |
| Official title | Autotransplantation and Her 2 Neu Antibody Immunotherapy in Advanced Breast Cancer |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | trastuzumab, carboplatin, carmustine, cisplatin, cyclophosphamide, thiotepa, peripheral blood stem cell transplantation |
| Enrollment | 0 |
| Start date | Jul 1, 2000 |
| Primary completion | Jul 1, 2000 |
| Completion | Jul 1, 2000 |
| First posted | Feb 12, 2004 |
| Last update posted | May 16, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: